NMD3 Inhibitors
NMD3 inhibitors represent a distinct class of chemical compounds that exert their influence at the molecular level, specifically within the intricate realm of nucleocytoplasmic transport processes. The nomenclature "NMD3" refers to the key protein targeted by these inhibitors, signifying the NucleoMagnin Domain-containing 3 protein. NMD3 plays a pivotal role in cellular function by participating in the export of ribosomal subunits from the nucleus to the cytoplasm, a fundamental step in the intricate machinery of protein synthesis. The inhibitors disrupt this finely tuned mechanism, impeding the normal progression of ribosomal subunit transport and thereby exerting a significant impact on cellular homeostasis.
NMD3 inhibitors are designed with a precise molecular architecture that enables them to interact selectively with the NMD3 protein. These compounds typically possess chemical moieties tailored to engage specific binding sites on NMD3, obstructing its normal functionality without triggering broader cellular dysfunction. The development of NMD3 inhibitors represents a nuanced approach in the field of molecular pharmacology, offering a means to dissect and manipulate cellular processes at the subcellular level. As researchers delve deeper into the structural intricacies of NMD3 inhibitors and their interaction with the target protein, novel insights into the regulation of nucleocytoplasmic transport emerge, opening avenues for further exploration in the realms of basic cellular biology and applications in diverse scientific domains.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is an inhibitor of exportin 1 (CRM1), a protein responsible for the nuclear export of many proteins, including potentially ribosomal subunits. By inhibiting CRM1, Leptomycin B might indirectly affect NMD3-dependent processes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates DNA, inhibiting RNA polymerase and thus downregulating rRNA transcription. This would indirectly reduce NMD3 function by limiting ribosome subunit availability. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 selectively inhibits RNA polymerase I, thereby blocking rRNA synthesis and potentially disrupting NMD3's role in ribosome subunit export. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
BMH-21 binds to RNA polymerase I and degrades it, leading to a halt in rRNA synthesis and potentially influencing NMD3 function indirectly. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that has been shown to inhibit RNA polymerase I, II, and III, which may affect NMD3 activity by reducing ribosome biosynthesis. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis at the level of translation elongation, which could potentially reduce the workload for NMD3 in ribosome subunit export. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide inhibits translation initiation, which may decrease the demand for NMD3's function in ribosome export. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol, a member of the flavagline class, inhibits translation initiation by targeting eIF4A, potentially affecting NMD3 function indirectly. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin is an adenosine analog that inhibits RNA polymerase and nucleotide synthesis, indirectly impacting NMD3 activity. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid is a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), affecting nucleotide biosynthesis and potentially influencing NMD3-related processes. | ||||||